New Zealand markets closed
  • NZX 50

    10,813.92
    +135.25 (+1.27%)
     
  • NZD/USD

    0.6319
    +0.0038 (+0.60%)
     
  • NZD/EUR

    0.5979
    +0.0017 (+0.29%)
     
  • ALL ORDS

    6,762.40
    +71.00 (+1.06%)
     
  • ASX 200

    6,578.70
    +50.30 (+0.77%)
     
  • OIL

    107.06
    +2.79 (+2.68%)
     
  • GOLD

    1,828.10
    -1.70 (-0.09%)
     
  • NASDAQ

    12,105.85
    +408.17 (+3.49%)
     
  • FTSE

    7,208.81
    +188.36 (+2.68%)
     
  • Dow Jones

    31,500.68
    +823.32 (+2.68%)
     
  • DAX

    13,118.13
    +205.54 (+1.59%)
     
  • Hang Seng

    21,719.06
    +445.19 (+2.09%)
     
  • NIKKEI 225

    26,491.97
    +320.72 (+1.23%)
     
  • NZD/JPY

    85.3920
    +0.7130 (+0.84%)
     

Cerebral Expands Opioid Use Disorder Treatment Program to Colorado, Washington

·2-min read

SAN FRANCISCO, May 26, 2022--(BUSINESS WIRE)--Cerebral Inc, the leading provider of online mental health services, today announced the expansion of its virtual opioid use disorder treatment program to include patients in Colorado and Washington state.

Cerebral began offering treatment for opioid use disorder -- aimed at increasing access to care and improving the health of people suffering from opioid addiction -- in Florida on March 8. The company plans to continue to expand to additional states.

There is a deep unmet need for treatment. There were more than 100,000 overdose deaths last year, 75 percent of which were opioid-related. However, 82 percent of Americans suffering from opioid use disorder are still not receiving the lifesaving medication they need, according to Pew.

"This expansion shows Cerebral’s commitment to helping patients who are struggling with opioid use, many of whom don’t know where to turn for help," said Cerebral Chief Executive Officer David Mou. "We are providing high-quality care as part of a program that has shown great success in treating a problem that continues to plague the U.S."

Cerebral patients who join the program will meet regularly with licensed prescribers to develop a personalized treatment plan, as well as manage or eliminate their opioid use, through medications like Suboxone. One-on-one counseling sessions supplement care. The sessions are virtual, so members can get care in the comfort and privacy of their home. Patients will take regular randomized drug tests during their check-ins with clinicians.

Cerebral treats a range of conditions, including anxiety, depression, ADHD, insomnia, bipolar disorder, and more. Cerebral recognizes the need for holistic treatment, as 43 percent of those struggling with opioid addiction also have a co-occurring diagnosis or symptoms of mental health disorders. Cerebral is on the path to becoming a comprehensive care provider so that it can pioneer value-based care in behavioral health.

About Cerebral

Cerebral’s mission is simple and straightforward: to improve access to affordable, high-quality, long-term mental health care to everyone who needs it. Unlike traditional mental health care, Cerebral is accessible, convenient, affordable, and free of stigma. With several full-service monthly subscription plans, members receive online access to prescribing providers, behavioral counselors, and talk therapists—all from the comfort of home or anywhere else with an internet connection. Cerebral’s monthly service plans are accessible with or without insurance. Visits are done via video chat, and members can message their care team directly. They’ll even receive medications delivered straight to their door (if prescribed). Cerebral was founded and launched in January 2020. For more information, visit cerebral.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005743/en/

Contacts

Dan Childs
(347) 986-7248
press@cerebral.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting